Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Innovation Creating More Innovation in Health Care

The Internet of Things (IoT) is making inroads not only in homes and industries, but in health care as well. While homes already have sensors regulating temperature room by room, turning lights on and off, and artificial intelligence (AI) learning residents’ habits, factories will soon find machine monitoring with communication to supervisors to reduce downtime….

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The Internet of Things (IoT) is making inroads not only in homes and industries, but in health care as well. While homes already have sensors regulating temperature room by room, turning lights on and off, and artificial intelligence (AI) learning residents’ habits, factories will soon find machine monitoring with communication to supervisors to reduce downtime. In health care, IoT will bring the industry to a new level entirely.

Some of the changes will be similar to what has been seen in homes and businesses, including more decentralized temperature control, more autonomous lighting and machine regulation. Along these lines, sensors will be attached to beds for on-time information about what beds are full, available or need to be changed—improving efficiency and cleanliness. Nurses will also be monitored to determine who is closest and available for a patient, nurse, doctor, or in the emergency room.

Other changes will make health care much more individualized. The industry has already seen a small step in place with Life Alert® or Lifeline with AutoAlert, which both monitor independent-living seniors for falls. There is absolutely no reason heart monitors, glucose monitors (like the Diabetes Digital Coach), pumps, and various other internal and external monitors cannot be connected to through IoT, with data sent to cell phones and/or to patients’ doctors.

As monitors become smaller and smaller, more and more aspects of people’s health can be monitored, and a day may come when a doctor may call a patient to tell them to get to the hospital right away before the patient has a heart attack.

Many mobile healthcare technologies have also been developed for remote regions in Africa and central Asia that are finding their way to the United States and Europe, including monitors that can be attached to a cell phone. This can mean either a return to actual home visits or even more extensive Teledoc calls.

There are many innovations still being developed which will improve health care, such as the smart bandage, which not only monitors skin conditions, but can deliver different medications if and when needed.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512